ERBB2 and breast carcinoma: In an attempt to address the co-delivery efficacy of PLGA nanocomposites, Lee et al. synthesized the ICG and DOX-encapsulated PEG-b-PLGA nanocomposites in figuring out the fabrication and characterization of anti-human epidermal growth factor receptor 2 (HER2) and applied them in overcoming the drug resistance of breast carcinoma [19,70,101].